Fast Site Qualification for a Phase 2 Parkinson’s Disease Study
For a recent Phase 2 Parkinson’s disease study, the Rho team went above and beyond to qualify sites as quickly as possible. The first site qualification visit (SQV) was conducted in June, and 3 months later, our team had 50 sites identified and fully qualified. This success was due to excellent coordination and communication with the sites and working with experienced, knowledgeable CRAs.
We have worked with Rho and their staff for over 17 years on at least a two dozen projects of which many were very complicated or had very stringent enrollment criteria. Their staff has been a joy to work with over the years.